Skip to main content
Home
Click here to request your free "Step By Step" support pack.
Toggle menu
  • Home
  • About Us
    • Our reports
    • Who we are
    • How we help
    • Our history
    • Our submissions and applications
    • Our member groups
    • Our supporters
    • Contact Us
  • About Breast Cancer
    • Detection
    • Diagnosis
    • Treatment
    • Clinical Trials
    • Books and Resources
  • Advanced Breast Cancer
    • Metavivors living life to the max
    • Legacy Videos
    • Treatment
    • Emotional Support
    • Support for Family and Friends
    • Further Support
    • Metavivors NZ
    • Metavivor Videos
    • Metavivors NZ - Action
    • Striving for Better Care
    • COVID-19 vaccination and breast cancer
    • Moana Papa: A secondary breast cancer diagnosis
  • Get Support
    • Support for You
    • Family Support
    • Getting on with Life
    • Support for Everyone
  • News
    • Latest News
    • Research News
    • BCAC press releases
    • Media Coverage
    • News from BCAC's member groups
    • BCAC's E Newsletters
  • Get Involved
    • Make a donation
    • Photo Gallery
    • Show Your Heart
  • Stories and Videos
    • Breast Cancer Foundation NZ webinars
    • Breast Cancer Trials Q and A sessions on video
    • Stories of Breast Cancer
    • Patient Videos
    • Advanced breast cancer - videos and photos
    • Tributes
  • Search

We Support

We provide a wide range of support and information to New Zealanders and their families who are experiencing breast cancer.

We Inform

We provide up to date information to empower those with breast cancer to make informed choices about their treatment and care.

We Represent

We provide a voice for those with breast cancer to ensure world-class detection, treatment and care is available in New Zealand.

Latest News

Submission to PHARMAC requesting funding of Perjeta for all who need it

Breast Cancer Aotearoa Coalition and Breast Cancer Foundation NZ have made a strongly worded and evidence-based joint submission to PHARMAC requesting that funding for Perjeta (pertuzumab) be extended to all people with HER2-positive advanced breast cancer.

The submission was made to the Cancer Treatment Sub-committee (known as CaTSoP).  At its September meeting, CaTSoP will consider applications for funding for the following breast cancer medicines – Perjeta, Kadcyla, Ibrance, Abraxane, Faslodex.

Attached is the joint submission sent to CaTSoP and the poster referred to in the letter.

24 July 2018

Read more

Meeting with decision makers to press for action to save and extend lives

Representatives of Breast Cancer Aotearoa Coalition (BCAC) went to Wellington recently to meet with Government and National MPs who have health responsibilities to discuss some of the key issues affecting those with breast cancer.

The two key issues highlighted by BCAC in the talks were the need to improve access to medicines; and the need to address inequities for Māori and Pasifika women in breast cancer screening and treatment.

The meetings were with the Associate Minister of Health Hon. Julie Anne Genter, Labour’s Health and Wellbeing Caucus member Hon. Louisa Wall and National’s Health spokesperson Hon. Michael Woodhouse.

Read more

PATINA

This is a randomized, open label, Phase III Trial to evaluate the efficacy and safety of Palbociclib + Anti-HER2 Therapy + Endocrine Therapy vs. Anti-HER2 Therapy + Endocrine Therapy after induction treatment for Hormone Receptor Positive (HR+)/HER2-Positive metastatic breast cancer.

Summary

This study is open to people diagnosed with hormone receptor (HR) positive, Human Epidermal Growth Factor Receptor 2 (HER-2) positive metastatic breast cancer. Despite significant improvements in the treatment of early-stage breast cancer, approximately 30% of women experience metastatic disease relapse. Development of therapies targeting the HER2 receptor has dramatically improved patient outcomes.

Read more

Major breast cancer study highlights urgent work needed

Important research released 21 June shows huge disparities in breast cancer screening, treatment and outcomes for Māori and Pasifika women in New Zealand.

The Breast Cancer Aotearoa Coalition (BCAC) says this is unacceptable and is calling for significant immediate steps to be taken to improve this situation.

The research, How to Improve Outcomes for Women with Breast Cancer in New Zealand, was funded by the Health Research Council through the University of Waikato with assistance from Waikato District Health Board. It was led by Professor Ross Lawrenson.

Read more

From three months to live to no sign of cancer: One woman’s experience increases optimism for immunotherapy

BCAC is thrilled a clinical trial involving American engineer Judy Perkins has led to her being declared free of breast cancer with what specialists are calling an extended remission. This wonderful news has come two years after she was told she had only three months to live. 

The trial of the experimental therapy was carried out by the US National Cancer Institute. BCAC are aware there is still much to learn before scientists can turn this experimental therapy into a treatment.

This work is complex but it is wonderful that it has been perfected for this one breast cancer patient,  and there is hope that ongoing research will see it eventually being extended to others -  potentially those whose tumours appear packed with immune cells. 

Read more

Many women won’t need chemotherapy when guided by a diagnostic test: US study

More women with the most common form of early stage breast cancer may not need chemotherapy and may instead rely on hormone therapies, according to a landmark study.

The findings in the study were based on a 21-tumor gene expression test which would also inform treatment decisions in real life.

BCAC says anecdotally there has been a perceived reluctance to use the Oncotype test in New Zealand because of concerns regarding its ability to accurately predict the risk of breast cancer recurrence and its cost.  We are very pleased that these results will allay some of those concerns.

Read more

Research underway into blood test to detect cancer

American researchers have hopes a new blood test they have developed may in the future be able to detect 10 types of cancer potentially years before someone becomes unwell.

The research team, with scientists from Cleveland Clinic's Taussig Cancer Institute and Standford University, say their test has been shown to pick up early signs of cancers including breast, ovarian, bowel and lung cancer. However, they note more work is needed before the results are conclusive and before the test can be used in the real world.

Read more

US study says low-fat diet may improve outlook for people experiencing breast cancer

Recent research has found that changing to a low-fat diet may have a positive influence on breast cancer outcomes.

A study led by Dr Rowan T Chlebowski, PhD of the City of Hope National Medical Center in California found that, in a randomized clinical trial, a low-fat eating pattern was associated with lower risk of death after breast cancer.

The study followed earlier research conducted at 40 US clinical centres that enrolled participants from 1993 to 1998. Participants were 48,835 postmenopausal women with no previous breast cancer and dietary fat intake of greater than 32% according to a questionnaire.

Read more

Poor report card on access to medicines, especially cancer medicines

BCAC says a new report highlights how desperately poor access to new and innovative medicines is in New Zealand.

The Medicines NZ Medicines Landscape 2017 report finds that New Zealand comes last out of 20 comparable OECD countries for access to publicly-funded new medicines.

The report says this means more than 230,000 patients in New Zealand are currently waiting for access to medicines that are not yet approved for public funding in this country.

The report highlights at least 80 medicines that are deemed to have a clinical benefit for patients and which have been recommended for public funding, but are not yet funded by the Government’s drug buying agency PHARMAC.

Read more

The breast tumour microenvironment: A target for therapy

BCAC committee member, Louise Malone, attended the San Antonio Breast Cancer Symposium in December 2017 and gives us an update on the latest cutting-edge research into new targeted immunotherapy treatments.

As cancer researchers better understand the complex interchanges between tumour cells and immune cells and the microenvironment in which they operate, new targets for therapy are emerging. 

Read more

Pagination

  • First page « first
  • Previous page ‹ previous
  • …
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Current page 26
  • Page 27
  • Page 28
  • Page 29
  • Page 30
  • …
  • Next page next ›
  • Last page last »

Click here to donate

Upcoming events

There are no Events currently.

About Us
Family Support
Patient Videos

About Us

The Breast Cancer Aotearoa Coalition (BCAC) provides a united voice for NZ women who are experiencing breast cancer. We support, inform and represent those with breast cancer so they can make informed choices about their treatment and care. Formed in 2004, BCAC is a registered charity run by breast cancer survivors. If you would like to join us to help improve breast cancer treatment and care in Aotearoa, New Zealand please email us to find out more. 

Connect online

Follow @BCACNZ
sfy39587stp18